Work

Results of a planned efficacy and safety analysis for a National Comprehensive Cancer Network sponsored phase II study of gemcitabine and irinotecan (GI) in metastatic breast cancer (MBC)

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.679

Authors: S. L. Moulder, P. Munster, S. Minton, N. Diaz, J. Horton, C. Rocha Lima, L. Hutson, D. Sullivan

Institutions: University of Miami, Moffitt Cancer Center

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589908907

Cites:

Cited by: 1

Related to: 10